» Articles » PMID: 3799638

Familial Ovarian Carcinoma. Clinical Nuances

Overview
Journal Am J Med
Specialty General Medicine
Date 1986 Dec 1
PMID 3799638
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Familial ovarian carcinoma has been recognized with increased frequency during the past decade commensurate with physician attention to family history. Putative autosomal dominant inheritance of this heterogeneous problem mandates attention to both paternal and maternal lineages. A family with probable paternal transmission of breast/ovarian carcinoma is presented. One family member had findings consonant with papillary serous adenocarcinoma of ovarian origin, which may have arisen directly from extra-ovarian pelvic mesothelium. These and other clinical nuances of familial ovarian carcinoma are discussed in order to aid physicians in understanding the natural history, surveillance, and management of familial ovarian carcinoma.

Citing Articles

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.

Olivier R, van Beurden M, Lubsen M, Rookus M, Mooij T, van de Vijver M Br J Cancer. 2004; 90(8):1492-7.

PMID: 15083174 PMC: 2409718. DOI: 10.1038/sj.bjc.6601692.


Cancer incidence in the first-degree relatives of ovarian cancer patients.

Auranen A, Pukkala E, Makinen J, Sankila R, Grenman S, Salmi T Br J Cancer. 1996; 74(2):280-4.

PMID: 8688336 PMC: 2074588. DOI: 10.1038/bjc.1996.352.


Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21.

Steichen-Gersdorf E, Gallion H, Ford D, Girodet C, Easton D, DiCioccio R Am J Hum Genet. 1994; 55(5):870-5.

PMID: 7977348 PMC: 1918337.


Microsatellite instability in ovarian neoplasms.

King B, Carcangiu M, Carter D, Kiechle M, Pfisterer J, Pfleiderer A Br J Cancer. 1995; 72(2):376-82.

PMID: 7640221 PMC: 2033989. DOI: 10.1038/bjc.1995.341.


Ovarian and cervical cancer.

Williams C BMJ. 1992; 304(6840):1501-4.

PMID: 1611377 PMC: 1882244. DOI: 10.1136/bmj.304.6840.1501.